glp-1 drug market news today Receptor Agonist Size GLP-1 Agonists Market Exclusive Research

Gastrointestinal safety assessment of GLP-1 receptor agonists in the US: a real-world adverse events analysis from the FAERS database

(August 2018)

Special populations and considerations Different patient populations have different considerations when it comes to choosing between insulin and GLP-1 therapy

Background Incretins are gut-derived peptide hormones secreted after nutrient intake to enhance glucose-dependent insulin release from pancreatic -cells

These re-dosed drugs are sold under the brand name Wegovy

Mazdutide's potential advantages lie in its glucagon component, which directly targets hepatic steatosis and may prove particularly valuable for patients with MASH or metabolic liver disease